Sweden
· Delayed Price · Currency is SEK Redsense Medical AB Statistics
Total Valuation
Redsense Medical AB has a market cap or net worth of SEK 113.47 million. The enterprise value is 105.35 million.
| Market Cap | 113.47M |
| Enterprise Value | 105.35M |
Important Dates
The last earnings date was Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Redsense Medical AB has 16.44 million shares outstanding. The number of shares has increased by 4.52% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 16.44M |
| Shares Change (YoY) | +4.52% |
| Shares Change (QoQ) | +12.45% |
| Owned by Insiders (%) | 3.40% |
| Owned by Institutions (%) | 27.57% |
| Float | 10.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.16 |
| PB Ratio | 3.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -26.50 |
| EV / Sales | 4.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.28 |
Financial Position
The company has a current ratio of 4.86
| Current Ratio | 4.86 |
| Quick Ratio | 3.85 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.29 |
Financial Efficiency
Return on equity (ROE) is -14.52% and return on invested capital (ROIC) is -8.97%.
| Return on Equity (ROE) | -14.52% |
| Return on Assets (ROA) | -7.77% |
| Return on Capital (ROIC) | -8.97% |
| Revenue Per Employee | 4.90M |
| Profits Per Employee | -795,200 |
| Employee Count | 5 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 4.06 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.07% in the last 52 weeks. The beta is 0.49, so Redsense Medical AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -17.07% |
| 50-Day Moving Average | 7.00 |
| 200-Day Moving Average | 6.71 |
| Relative Strength Index (RSI) | 49.22 |
| Average Volume (20 Days) | 4,281 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Redsense Medical AB had revenue of SEK 24.49 million and -3.98 million in losses. Loss per share was -0.27.
| Revenue | 24.49M |
| Gross Profit | 14.36M |
| Operating Income | -3.93M |
| Pretax Income | -3.98M |
| Net Income | -3.98M |
| EBITDA | -3.87M |
| EBIT | -3.93M |
| Loss Per Share | -0.27 |
Balance Sheet
| Cash & Cash Equivalents | 8.12M |
| Total Debt | n/a |
| Net Cash | 8.12M |
| Net Cash Per Share | 0.49 |
| Equity (Book Value) | 30.16M |
| Book Value Per Share | 1.95 |
| Working Capital | 16.32M |
Cash Flow
In the last 12 months, operating cash flow was -12.71 million and capital expenditures -17,000, giving a free cash flow of -12.73 million.
| Operating Cash Flow | -12.71M |
| Capital Expenditures | -17,000 |
| Free Cash Flow | -12.73M |
| FCF Per Share | -0.77 |
Margins
Gross margin is 58.63%, with operating and profit margins of -16.05% and -16.24%.
| Gross Margin | 58.63% |
| Operating Margin | -16.05% |
| Pretax Margin | -16.24% |
| Profit Margin | -16.24% |
| EBITDA Margin | -15.79% |
| EBIT Margin | -16.05% |
| FCF Margin | -51.98% |
Dividends & Yields
Redsense Medical AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.52% |
| Shareholder Yield | -4.52% |
| Earnings Yield | -3.90% |
| FCF Yield | -11.22% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Redsense Medical AB has an Altman Z-Score of 17.18.
| Altman Z-Score | 17.18 |
| Piotroski F-Score | n/a |